Delving into the Latest Updates on Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd. with Synapse

Overview

Basic Info

Introduction

Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd. specializes in the development of novel functional molecules aimed at treating metabolic and immune-related organ diseases. The company prides itself on its innovative and professional team and its platform, representing the latest strategic move by Fosun Pharma Group in the field of global pharmaceutical innovation.

Tags

Cardiovascular Diseases

Nervous System Diseases

Immune System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	2
Nervous System Diseases	1
Hemic and Lymphatic Diseases	1
Neoplasms	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	4

Top 5 Target	Count

MAPKAPK2(MAP kinase-activated protein kinase 2)	1
CFB(Complement factor B)	1
DPP-1(Cathepsin C)	1

主要目的：在COPD患者中，评价XH-S004片的安全性和耐受性。次要目的：在COPD患中，评价XH-S004片的药代动力学（PK）特征；在COPD患者中，评价XH-S004片主要的药效动力学（PD）指标特征；评价XH-S004片对COPD患者的肺功能指标的影响。

[Translation]

Primary objective: To evaluate the safety and tolerability of XH-S004 tablets in COPD patients. Secondary objectives: To evaluate the pharmacokinetic (PK) characteristics of XH-S004 tablets in COPD patients; To evaluate the main pharmacodynamic (PD) index characteristics of XH-S004 tablets in COPD patients; To evaluate the effect of XH-S004 tablets on lung function indicators in COPD patients.

Start Date-

Sponsor / Collaborator

Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.

100 Clinical Results associated with Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

2

Phase 1

Phase 2

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

XH-S003 ( CFB )	Glomerulonephritis, IGA More	Phase 2
XH-S002	Ischemic stroke More	Phase 1
XH-S004 ( DPP-1 )	Pulmonary Disease, Chronic Obstructive More	Phase 1
WO2025092739 ( MAPKAPK2 )Patent Mining	Atherosclerosis More	Discovery